Vanguard Personalized Indexing Management’s Civitas Resources CIVI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-27,021
Closed -$732K 2180
2025
Q4
$732K Sell
27,021
-12,666
-32% -$366K 0.01% 1057
2025
Q3
$1.29M Buy
39,687
+1,778
+5% +$56.9K 0.01% 780
2025
Q2
$1.04M Buy
37,909
+13,087
+53% +$379K 0.01% 856
2025
Q1
$866K Buy
24,822
+5,769
+30% +$255K 0.01% 863
2024
Q4
$874K Buy
19,053
+9,523
+100% +$474K 0.01% 833
2024
Q3
$483K Sell
9,530
-1,343
-12% -$83.2K 0.01% 1110
2024
Q2
$750K Sell
10,873
-1,284
-11% -$92.9K 0.01% 818
2024
Q1
$923K Sell
12,157
-9,080
-43% -$607K 0.02% 702
2023
Q4
$1.45M Buy
21,237
+14,226
+203% +$1.02M 0.04% 460
2023
Q3
$567K Buy
7,011
+271
+4% +$21K 0.02% 828
2023
Q2
$468K Buy
6,740
+496
+8% +$34.3K 0.01% 919
2023
Q1
$427K Buy
6,244
+2,277
+57% +$148K 0.01% 952
2022
Q4
$230K Buy
+3,967
New +$256K 0.01% 1082

Other funds holding CIVI

Vanguard Personalized Indexing Management's CIVI Position: Q1 2026 in Review

Vanguard Personalized Indexing Management sold out of Civitas Resources (CIVI) in Q1 2026, closing a stake of 27,021 shares — an estimated $732K sold.

Vanguard Personalized Indexing Management first reported a position in CIVI in Q4 2022 and held it in 13 quarters. The position peaked at $1.45M in Q4 2023. 2 funds tracked by Wall St. Rank hold CIVI as of Q1 2026.

  • Vanguard Personalized Indexing Management reported no remaining Civitas Resources position as of Q1 2026 after selling out during the quarter.
  • Vanguard Personalized Indexing Management sold 27,021 Civitas Resources shares in Q1 2026, an estimated $732K.
  • Vanguard Personalized Indexing Management first reported a position in Civitas Resources in Q4 2022 and held it in 13 quarters.
  • Vanguard Personalized Indexing Management's Civitas Resources position peaked at $1.45M in Q4 2023.
  • 2 funds tracked by Wall St. Rank held Civitas Resources as of Q1 2026.

Based on Vanguard Personalized Indexing Management's 13F filing for Q1 2026, filed 14 May 2026.